ProShare Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$52K Sell
21,222
-271
-1% -$664 ﹤0.01% 1989
2025
Q1
$143K Sell
21,493
-1,354
-6% -$9.03K ﹤0.01% 1768
2024
Q4
$287K Buy
22,847
+5,035
+28% +$63.3K ﹤0.01% 1664
2024
Q3
$329K Buy
17,812
+3,802
+27% +$70.2K ﹤0.01% 1402
2024
Q2
$302K Sell
14,010
-3,604
-20% -$77.6K ﹤0.01% 1287
2024
Q1
$475K Buy
17,614
+1,468
+9% +$39.5K ﹤0.01% 1117
2023
Q4
$484K Buy
16,146
+3,593
+29% +$108K ﹤0.01% 1053
2023
Q3
$257K Buy
12,553
+50
+0.4% +$1.02K ﹤0.01% 1297
2023
Q2
$248K Buy
12,503
+431
+4% +$8.56K ﹤0.01% 1401
2023
Q1
$207K Sell
12,072
-1,102
-8% -$18.9K ﹤0.01% 1427
2022
Q4
$258K Buy
13,174
+2,793
+27% +$54.7K ﹤0.01% 1326
2022
Q3
$167K Buy
10,381
+338
+3% +$5.44K ﹤0.01% 1449
2022
Q2
$139K Sell
10,043
-4,365
-30% -$60.4K ﹤0.01% 1550
2022
Q1
$229K Sell
14,408
-3,675
-20% -$58.4K ﹤0.01% 1802
2021
Q4
$394K Sell
18,083
-721
-4% -$15.7K ﹤0.01% 1618
2021
Q3
$562K Sell
18,804
-2,892
-13% -$86.4K ﹤0.01% 1138
2021
Q2
$961K Buy
21,696
+3,353
+18% +$149K ﹤0.01% 1062
2021
Q1
$814K Buy
18,343
+2,275
+14% +$101K ﹤0.01% 1114
2020
Q4
$881K Buy
16,068
+2,998
+23% +$164K ﹤0.01% 941
2020
Q3
$299K Sell
13,070
-373
-3% -$8.53K ﹤0.01% 1178
2020
Q2
$281K Buy
+13,443
New +$281K ﹤0.01% 1262
2020
Q1
Sell
-14,924
Closed -$340K 1494
2019
Q4
$340K Sell
14,924
-2,146
-13% -$48.9K ﹤0.01% 1267
2019
Q3
$199K Sell
17,070
-115
-0.7% -$1.34K ﹤0.01% 1446
2019
Q2
$258K Sell
17,185
-133
-0.8% -$2K ﹤0.01% 1317
2019
Q1
$304K Buy
17,318
+1,614
+10% +$28.3K ﹤0.01% 1250
2018
Q4
$233K Buy
+15,704
New +$233K ﹤0.01% 1289
2016
Q4
Sell
-4,671
Closed -$177K 1750
2016
Q3
$177K Sell
4,671
-781
-14% -$29.6K ﹤0.01% 1364
2016
Q2
$162K Buy
5,452
+601
+12% +$17.9K ﹤0.01% 1465
2016
Q1
$144K Sell
4,851
-458
-9% -$13.6K ﹤0.01% 1475
2015
Q4
$241K Buy
+5,309
New +$241K ﹤0.01% 1435